Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Dolutegravir versus raltegravir in antiretroviral-experienced, integrase-inhibitor-naive adults with HIV: week 48 results from the randomised, double-blind, non-inferiority SAILING study.

Dolutegravir versus raltegravir in antiretroviral-experienced, integrase-inhibitor-naive adults... http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png The Lancet Pubmed

Dolutegravir versus raltegravir in antiretroviral-experienced, integrase-inhibitor-naive adults with HIV: week 48 results from the randomised, double-blind, non-inferiority SAILING study.

Dolutegravir versus raltegravir in antiretroviral-experienced, integrase-inhibitor-naive adults with HIV: week 48 results from the randomised, double-blind, non-inferiority SAILING study.

The Lancet , Volume 382 (9893): -691 – Sep 9, 2013

Loading next page...
 
/lp/pubmed/dolutegravir-versus-raltegravir-in-antiretroviral-experienced-QHpRBkEKkL

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

ISSN
0140-6736
DOI
10.1016/S0140-6736(13)61221-0
pmid
23830355

Abstract

Journal

The LancetPubmed

Published: Sep 9, 2013

There are no references for this article.